Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.190
+0.020 (0.92%)
At close: Jun 26, 2026, 4:00 PM EDT
2.170
-0.020 (-0.91%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Aytu BioPharma Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Aytu BioPharma stock have an average target of 9.33, with a low estimate of 7.00 and a high estimate of 14. The average target predicts an increase of 326.03% from the current stock price of 2.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 15, 2026.
Analyst Ratings
The average analyst rating for Aytu BioPharma stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $7 | Buy | Reiterates | $7 | +219.63% | May 15, 2026 |
| Lake Street | Lake Street | Buy Maintains $7 | Buy | Maintains | $7 | +219.63% | May 14, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +539.27% | Mar 12, 2026 |
Financial Forecast
Revenue This Year
53.75M
from 66.38M
Decreased by -19.03%
Revenue Next Year
70.63M
from 53.75M
Increased by 31.41%
EPS This Year
-1.14
from -0.11
EPS Next Year
-0.08
from -1.14
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 54.8M | 72.0M | |
| Avg | 53.7M | 70.6M | |
| Low | 53.0M | 69.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -17.4% | 33.9% | |
| Avg | -19.0% | 31.4% | |
| Low | -20.1% | 30.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.02 | 0.25 | |
| Avg | -1.14 | -0.08 | |
| Low | -1.25 | -0.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.